Search Results - "Carroll, P V"

Refine Results
  1. 1

    Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review by Joshi, M.N, Whitelaw, B.C., Palomar, M.T.P., Wu, Y., Carroll, P.V.

    Published in Clinical endocrinology (Oxford) (01-09-2016)
    “…Summary Immune checkpoint inhibitors are a new and effective class of cancer therapy, with ipilimumab being the most established drug in this category. The…”
    Get full text
    Journal Article
  2. 2

    The Prevalence and Natural History of Pituitary Hemorrhage in Prolactinoma by Sarwar, K. N, Huda, M. S. B, Van de Velde, V, Hopkins, L, Luck, S, Preston, R, McGowan, B. M, Carroll, P. V, Powrie, J. K

    “…Context: Incidental pituitary hemorrhage, without full pituitary apoplexy, is a recognized radiological finding, but little information exists on its clinical…”
    Get full text
    Journal Article
  3. 3

    Factors determining the remission of microprolactinomas after dopamine agonist withdrawal by Huda, M. S. B., Athauda, N. B., Teh, M. M., Carroll, P. V., Powrie, J. K.

    Published in Clinical endocrinology (Oxford) (01-04-2010)
    “…Summary Background  Withdrawal of dopamine agonist (DA) therapy in the management of microprolactinoma is common practice, but it is unclear which patients are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Genetic predictors of cardiovascular morbidity in Bardet-Biedl syndrome by Forsythe, E., Sparks, K., Hoskins, B.E., Bagkeris, E., McGowan, B.M., Carroll, P.V., Huda, M.S.B., Mujahid, S., Peters, C., Barrett, T., Mohammed, S., Beales, P.L.

    Published in Clinical genetics (01-04-2015)
    “…Bardet–Biedl syndrome is a rare ciliopathy characterized by retinal dystrophy, obesity, intellectual disability, polydactyly, hypogonadism and renal…”
    Get full text
    Journal Article
  6. 6

    Cerebral cavernoma: an emerging long-term consequence of external beam radiation in childhood by Liu, Y., Preston, R., Thomas, S. M., Brackenridge, A., Carroll, P. V.

    Published in Clinical endocrinology (Oxford) (01-11-2010)
    “…Summary The long‐term effects of cranial external beam radiotherapy are emerging as survival rates for cerebral tumours improve. Cerebral cavernoma are a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Thomas Addison's disease after 154 years: modern diagnostic perspectives on an old condition by Leelarathna, L., Powrie, J.K., Carroll, P.V.

    Published in QJM : An International Journal of Medicine (01-08-2009)
    “…Thomas Addison was first to describe adrenocortical failure in 1855. Despite advances in the treatment of this condition, the diagnosis is still often delayed…”
    Get full text
    Journal Article
  9. 9

    The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement by Swords, F. M., Carroll, P. V., Kisalu, J., Wood, P. J., Taylor, N. F., Monson, J. P.

    Published in Clinical endocrinology (Oxford) (01-11-2003)
    “…Summary objective  11β‐hydroxysteroid dehydrogenase type 1 (11βHSD1) converts inactive cortisone to active cortisol. 11βHSD1 activity is increased in GH…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion by Carroll, P. V., Monson, J. P., Grossman, A. B., Besser, G. M., Plowman, P. N., Afshar, F., Savage, M. O.

    Published in Clinical endocrinology (Oxford) (01-02-2004)
    “…Summary objective  Although Cushing's disease (CD) rarely occurs in childhood, affected children commonly fail to achieve predicted adult height…”
    Get full text
    Journal Article
  12. 12

    metabolic consequences of critical illness: acute effects on glutamine and protein metabolism by Jackson, N.C, Carroll, P.V, Russell-Jones, D.L, Sonksen, P.H, Treacher, D.F, Umpleby, A.M

    “…Net protein loss and large decreases in plasma glutamine concentration are characteristics of critical illness. We have used [2-15N]glutamine and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours by Kumar, J., Spring, M, Carroll, P. V., Barrington, S. F., Powrie, J. K.

    Published in Clinical endocrinology (Oxford) (01-04-2006)
    “…Summary Objective  Neuroendocrine tumours (NET) are a rare cause of Cushing's syndrome. These tumours can be very small and therefore difficult to identify…”
    Get full text
    Journal Article
  15. 15

    Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients by Jackson, N C, Carroll, P V, Russell-Jones, D L, Sönksen, P H, Treacher, D F, Umpleby, A M

    “…During critical illness glutamine deficiency may develop. Glutamine supplementation can restore plasma concentration to normal, but the effect on glutamine…”
    Get more information
    Journal Article
  16. 16

    IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp by CARROLL, P. V, CHRIST, E. R, UMPLEBY, A. M, GOWRIE, I, JACKSON, N, BOWES, S. B, HOVORKA, R, CROOS, P, SÖNKSEN, P. H, RUSSELL-JONES, D. L

    Published in Diabetes (New York, N.Y.) (01-05-2000)
    “…IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino…”
    Get full text
    Journal Article
  17. 17

    Transitional care of GH deficiency: when to stop GH therapy by Savage, MO, Drake, WM, Carroll, PV, Monson, JP

    Published in European journal of endocrinology (01-08-2004)
    “…While the benefits of growth hormone (GH) therapy in adult hypopituitary patients with GH deficiency (GHD) are established, the role of continued GH therapy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Growth Hormone Replacement in Adults with Growth Hormone Deficiency: Assessment of Current Knowledge by Carroll, Paul V., Christ, Emanuel R., Sönksen, Peter H.

    Published in Trends in endocrinology and metabolism (01-08-2000)
    “…The recent availability of recombinant human growth hormone (GH) has led to intense investigation of the consequences of adult GH deficiency (GHD) and the…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus by Christ, E. R., Carroll, P. V., Albany, E., Umpleby, A. M., Lumb, P. J., Wierzbicki, A. S., Simpson, H. L., Sönksen, P. H., Russell-Jones, D. L.

    Published in Clinical endocrinology (Oxford) (01-12-2001)
    “…OBJECTIVES Patients with type 1 diabetes are at increased risk of cardiovascular disease, which may be related to abnormal lipid metabolism. Secretion and…”
    Get full text
    Journal Article